Supraventricular Tachycardia
📧 Sign up to get email alerts when something new happens for Supraventricular Tachycardia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Validity and Algorithm Development for Detection of Supraventricular Tachycardia in Children-A Clinical Pilot Study
This clinical trial update describes a pediatric pilot study to validate validity and develop an algorithm for detecting supraventricular ta…
-
FDA approval · 2026-04-10FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for diltiazem hydrochloride from ScieGen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Adenosine vs. Diltiazem [Phase 4]
Phase 4 trial comparing adenosine versus diltiazem in supraventricular tachycardia and atrioventricular nodal reentrant tachycardia has comp…
-
FDA approval · 2026-02-27FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original abbreviated new drug application for diltiazem hydrochloride from Macleods Pharmaceuticals Limited.
-
FDA approval · 2026-02-23FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
The FDA approved a supplemental application for diltiazem hydrochloride from Zydus Pharmaceuticals USA Inc., approving a generic product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-02-09FDA Approved: DIGOXIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Digoxin submitted by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Rate, Rhythm or Risk Control for New-onset Supraventricular Arrhythmia During Septic Shock: a Randomized Controlled Trial [NA]
A randomized controlled trial is evaluating rate, rhythm, or risk-control strategies for new-onset supraventricular tachycardia during septi…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Management of Supraventricular Tachycardias in Children
This clinical trial from the Paris Cardiovascular Research Center evaluating management options for supraventricular tachycardia in children…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Evaluation of a Single-lead ECG Patch-based Telemetry System for In-hospital Monitoring [NA]
A clinical trial update on a single-lead ECG patch telemetry system for in-hospital monitoring, currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Shortening Duration of Antiarrhythmic Medication for SVT in Infants
A completed clinical trial evaluated whether shortening the duration of antiarrhythmic therapy is feasible for infants with supraventricular…
-
FDA approval · 2025-11-14FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves the original application for diltiazem hydrochloride (Alembic Pharmaceuticals Limited), a generic product, for use in treating …
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Electrophysiological Registry Duesseldorf
A clinical electrophysiology registry by Heinrich-Heine University in Duesseldorf is currently recruiting to study atrial fibrillation, atri…
-
FDA approval · 2025-09-19FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for verapamil hydrochloride from Amneal Pharmaceuticals LLC under ANDA210994. This approval authoriz…
-
FDA approval · 2025-09-11FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for diltiazem hydrochloride from Actavis Pharma, Inc., confirming/expanding the product's regulatory…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Adenosine vs Diltiazem for Treatment of SVT in the ED [Phase 4]
A Phase 4 trial is comparing adenosine and diltiazem for treating supraventricular tachycardia in the emergency department, and the study is…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Outcome of SVT in Children Admitted to AUCH
Administrative update on a clinical trial assessing outcomes of supraventricular tachycardia in children, with the study not yet recruiting.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure [NA]
A Yonsei University study is evaluating beta-blockers to prevent supraventricular arrhythmias after patent foramen ovale (PFO) closure; the …
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency Department
A clinical trial comparing diltiazem to adenosine for treating supraventricular tachycardia in the emergency department. The study is curren…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Clinical Study on the Safety and Efficacy of a New Magnetic Navigation Radiofrequency Ablation Catheter for Rapid Arrhythmia [NA]
A clinical study is evaluating a new magnetic navigation radiofrequency ablation catheter for rapid arrhythmias; the trial is currently not …
-
FDA approval · 2025-07-02FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved a generic diltiazem hydrochloride product from Ingenus Pharmaceuticals under an Original Application (ANDA), expanding access t…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Clinical Safety and Efficacy Testing of a Medical Device Kardi Ai, an ECG Telemetry Monitoring System [NA]
A clinical trial is evaluating the safety and efficacy of the Kardi Ai ECG telemetry monitoring system; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia
A prospective observational cohort study of fetal atrial flutter and fetal supraventricular tachycardia has completed.
-
FDA approval · 2025-04-16FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental NDA for the extended-release form of diltiazem hydrochloride.
-
FDA label_change · 2025-04-16FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
FDA approves a supplemental application for Cardizem CD (diltiazem hydrochloride) by Bausch Health US LLC.
-
FDA approval · 2025-04-16FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for diltiazem hydrochloride by Oceanside Pharmaceuticals.